8 results

• Dupixent Lawyers To Meet With Court for Initial Conference in T-Cell Lymphoma Lawsuit

  October 17, 2025

  Irvin Jackson

  Parties involved in a Dupixent T-cell lymphoma wrongful death lawsuit will participate in an initial status conference in early December, to map out how the litigation will move forward.

• Dupixent Cancer Risks Outlined in User Stories, as Evidence Mounts of T-Cell Lymphoma Link

  October 8, 2025

  Russell Maas

  Dupixent users are coming forward with accounts of devastating cancer diagnoses, saying the popular eczema drug masked early warning signs of cutaneous T-cell lymphoma. As the FDA investigates and the first lawsuit is filed, researchers warn Dupixent may unmask or accelerate hidden cancers, raising urgent questions about its long-term safety.

• Dupixent Wrongful Death Lawsuit Filed Over T-Cell Lymphoma Diagnosis

  October 2, 2025

  Irvin Jackson

  A Dupixent lawsuit blames the atopic dermatitis drug for causing a woman to develop a deadly form of cancer, which caused her death.

• Dupixent Side Effects May Increase Cutaneous T-Cell Lymphoma (CTCL) Risks

  August 26, 2025

  Irvin Jackson

  Recent studies warn that the eczema treatment Dupixent appears to significantly increase the risk of cutaneous T-cell lymphoma (CTCL).

• Some Hypertension Drugs May Increase Risk of Eczema in Older Patients, Study Warns

  June 4, 2024

  Martha Garcia

  A new study links the use of blood pressure medications to an increased risk of eczema, with some types of hypertension medications causing a higher risk than others.

• Prenatal Exposure to Opioids Linked to Higher Risk of Infections, Skin Problems: Study

  January 24, 2024

  Katherine McDaniel

  A new study links prenatal exposure to opioids to an increased risk of infections, respiratory and skin problems among newborns and young children.

• Diep Bao Baby Skin Cream Recall Issued Over Lead Poisoning Risks

  February 3, 2023

  Martha Garcia

  A Diep Bao skin cream recall was announced after two young children were found to have elevated levels of lead in their blood following exposure to the eczema treatment.

• Opzelura Eczema Cream Investigation Announced Over Texture Problems

  November 4, 2021

  Irvin Jackson

  The eczema cream Opzelura, made from the same active ingredient as Jakafi, is being investigated for texture issues as the entire class of drugs faces scrutiny over heart and cancer risks.